@article {20417,
	title = {Platelet-rich Blood Derivatives for Tendon Regeneration},
	journal = {Journal Of The American Academy Of Orthopaedic Surgeons},
	volume = {28},
	year = {2020},
	month = {2020-03-01 00:00:00},
	pages = {e202-e205},
	publisher = {Wolters Kluwer},
	abstract = {<p><span>Tendon injuries constitute a significant healthcare problem with variable clinical outcomes. The complex interplay of tissue homeostasis, degeneration, repair, and regeneration makes the development of successful delivery therapeutic strategies challenging. Platelet-rich hemoderivatives, a source of supra-physiologic concentrations of human therapeutic factors, are a promising application to treat tendon injuries from the perspective of tendon tissue engineering, although the outcomes remain controversial.</span></p>},
	keywords = {Platelet-rich haemoderivatives, Tendon},
	issn = {1067-151X},
	doi = {10.5435/JAAOS-D-18-00638},
	author = {Costa-Almeida, R. and Babo, P. S. and Reis, R. L. and Gomes, M. E.}
}
